INVESTOR NEWS

Nov 06, 2026

Grant of options

Moss, 6 November 2026 Reference is made to the annual general meeting 6 May 2025 where guidelines for..

Oct 13, 2026

Gentian Diagnostics: Invitation to presentation of third quarter results

Gentian Diagnostics ASA will present its third quarter 2026 results on 20 October 2026 at 09.00 CEST.

Jul 02, 2026

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

Jun 24, 2026

ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

May 29, 2026

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

May 13, 2026

Flaggemelding – Gentian Diagnostics ASA

Melding etter verdipapirhandelloven § 4-2 Oslo, 13 mai 2026 Vatne Capital AS, kontrollert av Runar Vatne, har..

May 13, 2026

Board resignation

Moss, 13 May 2026 Reference is made to the stock exchange release regarding Vatne Capital’s notification of..